Forecast & Rating3 analysts currently cover Fibrobiologics, of which 1 give a positive rating. The average price target is $12.50, about 774.1% upside from the current price of $1.43. Coverage is limited, so the data is for reference only. Data as of Aug 4, 2026; this does not constitute investment advice.
Aug 4, 2026Price forecast
$12.50774.13%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy0.00%
- Hold50.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 14, 2026
Forecast met0.0%
Stock price$1.43
Avg. target$12.5
High target$19
Low target$6
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.